HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,153-1,164 of 7,264
Device study icon
Not Yet RecruitingNCT06899893

The Research Team Aims to Elucidate the Impact of ITBS (intermittent Theta Burst Stimulation) on the HPA Axis and Post-stroke Negative Emotions/depression by Conducting Human Experiments That Target Various Brain Regions.

Official study title

Investigating the Impact of ITBS Stimulation on Various Brain Regions on the HPA Axis in Stroke Patients Using Resting-State EEG Data.

This study isn't recruiting yet.

Location not clearly listed
DepressionDevice studyAges 18–85
Countries
Sponsor
The Second Affiliated Hospital of Kunming Medical University
Device study icon
Not Yet RecruitingNCT06813313

Theta Burst Stimulation With an 8-Coil Versus H1-Coil for Resistant Depression

Official study title

Randomized Controlled Trial of Two Accelerated Transcranial Magnetic Stimulation Methods in the Treatment of Resistant Depression: Intermittent Theta Burst Stimulation With an 8-Coil Versus H1-Coil

This study isn't recruiting yet.

Location not clearly listed
DepressionDevice studyAges 18+
Countries
Sponsor
Dominique JANUEL
Drug study icon
CompletedNCT06309277

Of Single and Multiple Oral Doses of GM-1020 for Depression

What is this study about?

This study evaluated the safety of GM-1020 for people with depression.

This study has finished and is no longer accepting participants.

In Manchester
DepressionMedication studyAges 18–65
Countries
United Kingdom
Sponsor
Gilgamesh Pharmaceuticals
Drug study icon
CompletedNCT00128479

A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

What is this study about?

Researchers compared mifepristone, mifepristone 600 mg, mifepristone 1200 mg and placebo, tracking side effects to assess safety in people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
Depression, SchizophreniaMedication studyAges 18–75
Countries
United States
Sponsor
Corcept Therapeutics

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.